Acute myeloid leukaemia trials in Uzbekistan

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients

  Where

  Tashkent

  Age

  18 years and over

  People

  66 worldwide

  Run by

  Lomond Therapeutics Holdings, Inc.

  See details and how to joinNCT07303660